Skip to main content
Premium Trial:

Request an Annual Quote

Celera Licenses Proteome s Protein Database

NEW YORK, Sept 14 -

Celera Genomics (NYSE: CRA) has licensed Proteome's BioKnowledge Library for distibution in the Celera Discovery System, Proteome said Thursday.

The research library is comprised of a collection of searchable Proteome Databases that include information about proteins of specific organisms, including human, worm, and yeast.

Financial terms of the deal were not disclosed.

The collaboration will combine Celera's structural and functional genomics information with Proteome's protein information. Proteome said access to the combined data could help in the drug discovery process.

Proteome of Beverly, Mass., is a privately held company that uses its proprietary technology to analyze the human proteome.

Celera of Rockville, Md., has said that it plans to become a leader in industrialized proteomics.

Shares of Celera were up 2, or 2 percent, at 101 7/8 in midday trading.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.